Hepatitis B virus infections in pregnant women and children in the era of HBV elimination

Malgorzata Pawlowska

doi:10.5114/ceh.2024.145364

eISSN: 2449-8238
ISSN: 2392-1099

Clinical and Experimental Hepatology

Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Send email

Copy url:

abstract:

Review paper

Hepatitis B virus infections in pregnant women and children in the era of HBV elimination

Malgorzata Pawlowska

¹

Department of Infectious Diseases and Hepatology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland

Clin Exp HEPATOL 2024; 10, 4:

DOI: https://doi.org/10.5114/ceh.2024.145364

Online publish date: 2024/12/18

View full text Get citation

PlumX metrics:

In the hepatitis B virus (HBV) elimination strategy announced by the World Health Organization (WHO) in 2016, one of the main aspects is the prevention of vertical infections. In the prevention of vertical HBV infections, chemoprophylaxis with tenofovir is recommended from the 28^th week of pregnancy in women with a high viral load (HBV DNA > 2 × 10⁵ IU/ml) or the presence of HBeAg in the serum and active-passive immunoprophylaxis (HepB-BD+ HBIG) in all newborns born to mothers infected with HBV. Attention was paid to the incidence of latent HBV infections among children and adolescents and the role of the vaccine dose and additional hepatitis B booster vaccination in the prevention of HBV, especially in highly endemic areas and risk groups. The role of the age of initiation of therapy in the context of functional cure was indicated.

keywords:

Hepatitis B virus infections in pregnant women and children in the era of HBV elimination

Malgorzata Pawlowska 1

HBV, vertical infections, prevention, occult HBV infections, children

Malgorzata Pawlowska

¹